This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovations of Jun Lu in PCSK9 Antagonists
Introduction
Jun Lu is an accomplished inventor based in Lansdale, PA (US). He has made significant contributions to the field of biochemistry, particularly in the development of antagonists for human proprotein convertase subtilisin-kexin type 9 (PCSK9). His work is crucial for advancing treatments for conditions associated with PCSK9 activity.
Latest Patents
Jun Lu holds a patent for AX132 PCSK9 antagonists. This patent discloses antagonists that effectively inhibit PCSK9 function. The invention includes nucleic acids encoding these antagonists, vectors, host cells, and compositions comprising the antagonists. Additionally, it outlines methods for creating PCSK9-specific antagonists and their applications in inhibiting or antagonizing PCSK9 function.
Career Highlights
Jun Lu is currently employed at Merck Sharp & Dohme Corporation, where he continues to innovate in the field of biopharmaceuticals. His expertise in PCSK9 antagonists positions him as a key player in developing new therapeutic strategies.
Collaborations
He has collaborated with notable colleagues, including Peter Peizhi Luo and Kevin Caili Wang. Their combined efforts contribute to the advancement of research in this vital area of medicine.
Conclusion
Jun Lu's work on PCSK9 antagonists represents a significant advancement in the treatment of related health conditions. His contributions to the field are invaluable and highlight the importance of innovation in biochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile